bit.bio discovery specialises in functional genomic screening in induced pluripotent stem cell (iPSC) derived models of health and disease. Our mission is to accelerate drug discovery programs of pharmaceutical and biotech companies by leveraging cutting-edge CRISPR technology within the realm of human iPSC models. Our innovative approach is applicable across a wide range of biological questions and disease areas with CRISPR knockout, CRISPR activation and CRISPR interference technologies available. Our team of researchers is highly experienced and specialised in cellular engineering, iPSC biology and differentiation, CRISPR screening approaches and bioinformatic analysis.
